Discrete event simulation applied to pediatric phase I oncology designs.
about
Evaluation of agile designs in first-in-human (FIH) trials--a simulation studyIntegration of PKPD relationships into benefit-risk analysisInnovations for phase I dose-finding designs in pediatric oncology clinical trials.Addressing the variation of post-surgical inpatient census with computer simulation.
P2860
Discrete event simulation applied to pediatric phase I oncology designs.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Discrete event simulation applied to pediatric phase I oncology designs.
@en
Discrete event simulation applied to pediatric phase I oncology designs.
@nl
type
label
Discrete event simulation applied to pediatric phase I oncology designs.
@en
Discrete event simulation applied to pediatric phase I oncology designs.
@nl
prefLabel
Discrete event simulation applied to pediatric phase I oncology designs.
@en
Discrete event simulation applied to pediatric phase I oncology designs.
@nl
P2093
P2860
P356
P1476
Discrete event simulation applied to pediatric phase I oncology designs.
@en
P2093
P2860
P2888
P304
P356
10.1038/CLPT.2008.193
P407
P577
2008-10-15T00:00:00Z
P6179
1032759570